Birgitte Volck
Director/Board Member at SOLENO THERAPEUTICS, INC.
Net worth: 301 526 $ as of 2024-03-30
Profile
Currently, Birgitte Volck holds the position of SVP, Head-Clinical Development & Medical Affairs at Ascendis Pharma A. Dr. Volck is also on the board of Soleno Therapeutics, Inc. and Vaccibody AS. Dr. Volck previously occupied the position of Head-Research & Development at GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development at Swedish Orphan Biovitrum AB, President-Research & Development at Avrobio, Inc., Director-Executive Development at Amgen, Inc., Director-Nordic Medical & Project Director at Genzyme Danmark and Head-Clinical Development & Medical Affairs at Pharmexa A. Birgitte Volck received a doctorate from the University of Copenhagen.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SOLENO THERAPEUTICS INC
0.02% | 2023-05-25 | 7,045 ( 0.02% ) | 301 526 $ | 2024-03-30 |
Birgitte Volck active positions
| Companies | Position | Start |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Director/Board Member | 2019-06-09 |
| NYKODE THERAPEUTICS | Director/Board Member | 2021-05-04 |
Former positions of Birgitte Volck
| Companies | Position | End |
|---|---|---|
| ASCENDIS PHARMA A/S | Chief Tech/Sci/R&D Officer | 2023-11-30 |
| AVROBIO, INC. | Chief Tech/Sci/R&D Officer | 2020-09-30 |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Director/Board Member | 2019-12-31 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 2018-07-31 |
| WILSON THERAPEUTICS AB | Director/Board Member | 2018-04-30 |
Training of Birgitte Volck
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| AMGEN INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| NYKODE THERAPEUTICS | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AVROBIO, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Commercial Services |
TFS Trial Form Support International AB
 TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Commercial Services |
| Genzyme Danmark | |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Birgitte Volck
